Interleukin-2 and PD-1 synergistically modify T cell exhaustion programs

Am J Transplant. 2023 Feb;23(2):161-162. doi: 10.1016/j.ajt.2023.01.002. Epub 2023 Jan 14.

Authors

Paolo Cravedi¹, Xian C Li²

Affiliations

¹ Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Houston, Texas, USA. Electronic address: xcli@houstonmethodist.org.

PMID: 36717354
DOI: 10.1016/j.ajt.2023.01.002

No abstract available

Publication types

Comment

MeSH terms

CD8-Positive T-Lymphocytes
Hepatitis A Virus Cellular Receptor 2
Interleukin-2*
Programmed Cell Death 1 Receptor*
T-Cell Exhaustion

Substances

Interleukin-2
Programmed Cell Death 1 Receptor
Hepatitis A Virus Cellular Receptor 2